{"@context":"https://schema.org","@type":"Corporation","name":"GLENMARK PHARMACEUTICALS","alternateName":"GLENMARK","tickerSymbol":"GLENMARK","identifier":"GLENMARK","description":"GLENMARK PHARMACEUTICALS (GLENMARK) financials: Market Cap ₹64,432Cr., Price ₹2,283, P/E 44.1, ROE 3.87%. Jun 2026: sales ₹2,435 Cr, net profit ₹736 Cr. Quarte…","url":"https://fincrux.org/companies/GLENMARK","sameAs":["https://fincrux.org/companies/GLENMARK"],"dateModified":"2026-10-13T05:26:47.334958","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹64,432Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹2,283"},{"@type":"PropertyValue","name":"Stock P/E","value":"44.1"},{"@type":"PropertyValue","name":"ROE","value":"3.87%"},{"@type":"PropertyValue","name":"ROCE","value":"6.51%"},{"@type":"PropertyValue","name":"Book Value","value":"₹856"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.22%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹2,538/1,793"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/GLENMARK#webpage","name":"GLENMARK PHARMACEUTICALS (GLENMARK) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/GLENMARK","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/GLENMARK"}}